State Board Of Administration Of Florida Retirement System Cardiff Oncology, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$53.7 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$1.17 - $2.61 $35,266 - $78,670	-30,142 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$5.01 - $7.58 $97,544 - $147,582	19,470 Added 182.44%	30,142 $201,000
Q2 2021 Aug 10, 2021	BUY	$6.65 - $10.04 $70,968 - $107,146	10,672 New	10,672 $71,000

Others Institutions Holding CRDF

# of Institutions

Shares Held

8.48M

Call Options Held

798K

Put Options Held

39.2K

Vanguard Group Inc Valley Forge, PA

1.92M
Shares

$4.27 Million
0.0% of portfolio
Laurion Capital Management LP New York, NY

929K
Shares

$2.06 Million
0.04% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

683K
Shares

$1.52 Million
0.0% of portfolio
Black Rock Inc. New York, NY

677K
Shares

$1.5 Million
0.0% of portfolio
Mai Capital Management

551K
Shares

$1.22 Million
0.03% of portfolio

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $96.2M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account